Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.

Urtishak KA, Wang LS, Culjkovic-Kraljacic B, Davenport JW, Porazzi P, Vincent TL, Teachey DT, Tasian SK, Moore JS, Seif AE, Jin S, Barrett JS, Robinson BW, Chen IL, Harvey RC, Carroll MP, Carroll AJ, Heerema NA, Devidas M, Dreyer ZE, Hilden JM, Hunger SP, Willman CL, Borden KLB, Felix CA.

Oncogene. 2019 Mar;38(13):2241-2262. doi: 10.1038/s41388-018-0567-7. Epub 2018 Nov 26.

2.

Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci.

Yu X, Davenport JW, Urtishak KA, Carillo ML, Gosai SJ, Kolaris CP, Byl JAW, Rappaport EF, Osheroff N, Gregory BD, Felix CA.

Genome Res. 2017 Jul;27(7):1238-1249. doi: 10.1101/gr.211615.116. Epub 2017 Apr 6.

3.

Unique Familial MLL(KMT2A)-Rearranged Precursor B-Cell Infant Acute Lymphoblastic Leukemia in Non-twin Siblings.

Urtishak KA, Robinson BW, Rappaport EF, Sarezky MD, Biegel JA, Nichols KE, Wilmoth DM, Wang LS, Stern JW, Felix CA.

Pediatr Blood Cancer. 2016 Jul;63(7):1175-80. doi: 10.1002/pbc.25957. Epub 2016 Mar 21.

PMID:
26999444
4.

Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease.

Peng M, Ostrovsky J, Kwon YJ, Polyak E, Licata J, Tsukikawa M, Marty E, Thomas J, Felix CA, Xiao R, Zhang Z, Gasser DL, Argon Y, Falk MJ.

Hum Mol Genet. 2015 Sep 1;24(17):4829-47. doi: 10.1093/hmg/ddv207. Epub 2015 Jun 3.

5.

Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).

Dreyer ZE, Hilden JM, Jones TL, Devidas M, Winick NJ, Willman CL, Harvey RC, Chen IM, Behm FG, Pullen J, Wood BL, Carroll AJ, Heerema NA, Felix CA, Robinson B, Reaman GH, Salzer WL, Hunger SP, Carroll WL, Camitta BM.

Pediatr Blood Cancer. 2015 Mar;62(3):419-26. doi: 10.1002/pbc.25322. Epub 2014 Nov 14.

6.

Topoisomerase II and leukemia.

Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N.

Ann N Y Acad Sci. 2014 Mar;1310:98-110. doi: 10.1111/nyas.12358. Epub 2014 Feb 3. Review.

7.

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

Urtishak KA, Edwards AY, Wang LS, Hudome A, Robinson BW, Barrett JS, Cao K, Cory L, Moore JS, Bantly AD, Yu QC, Chen IM, Atlas SR, Willman CL, Kundu M, Carroll AJ, Heerema NA, Devidas M, Hilden JM, Dreyer ZE, Hunger SP, Reaman GH, Felix CA.

Blood. 2013 Apr 4;121(14):2689-703. doi: 10.1182/blood-2012-04-425033. Epub 2013 Feb 7.

8.

Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW, Valsecchi MG, Pieters R, Heerema NA, Hilden JM, Felix CA, Reaman GH, Camitta B, Winick N, Carroll WL, Dreyer ZE, Hunger SP, Willman CL.

Blood. 2012 Feb 23;119(8):1872-81. doi: 10.1182/blood-2011-10-382861. Epub 2011 Dec 30.

9.

Molecular pathogenesis of secondary acute promyelocytic leukemia.

Joannides M, Mays AN, Mistry AR, Hasan SK, Reiter A, Wiemels JL, Felix CA, Coco FL, Osheroff N, Solomon E, Grimwade D.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011045. doi: 10.4084/MJHID.2011.045. Epub 2011 Oct 24.

10.

mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.

Robinson BW, Germano G, Song Y, Abrams J, Scott M, Guariento I, Tiso N, Argenton F, Basso G, Rhodes J, Kanki JP, Look AT, Balice-Gordon RJ, Felix CA.

Br J Haematol. 2011 Feb;152(3):307-21. doi: 10.1111/j.1365-2141.2010.08398.x. Epub 2010 Dec 14.

11.

Infant leukemia 2010: a call to action for the west and the "four Asian Tigers".

Felix CA.

Pediatr Blood Cancer. 2010 Dec 15;55(7):1247-9. doi: 10.1002/pbc.22817. No abstract available.

PMID:
20981686
12.

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia.

Mays AN, Osheroff N, Xiao Y, Wiemels JL, Felix CA, Byl JA, Saravanamuttu K, Peniket A, Corser R, Chang C, Hoyle C, Parker AN, Hasan SK, Lo-Coco F, Solomon E, Grimwade D.

Blood. 2010 Jan 14;115(2):326-30. doi: 10.1182/blood-2009-07-235051. Epub 2009 Nov 2.

13.

A safer regimen for high-risk neuroblastoma.

Felix CA.

Pediatr Blood Cancer. 2009 Jul;53(1):3-6. doi: 10.1002/pbc.22020. No abstract available.

PMID:
19431215
14.

Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences.

Robinson BW, Felix CA.

Methods Mol Biol. 2009;538:85-114. doi: 10.1007/978-1-59745-418-6_6.

PMID:
19277575
15.

Effect of delivering light in specific narrow bandwidths from 394 to 515nm on the micro-hardness of resin composites.

Price RB, Felix CA.

Dent Mater. 2009 Jul;25(7):899-908. doi: 10.1016/j.dental.2009.01.098. Epub 2009 Feb 24.

PMID:
19243817
16.

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.

Hasan SK, Mays AN, Ottone T, Ledda A, La Nasa G, Cattaneo C, Borlenghi E, Melillo L, Montefusco E, Cervera J, Stephen C, Satchi G, Lennard A, Libura M, Byl JA, Osheroff N, Amadori S, Felix CA, Voso MT, Sperr WR, Esteve J, Sanz MA, Grimwade D, Lo-Coco F.

Blood. 2008 Oct 15;112(8):3383-90. doi: 10.1182/blood-2007-10-115600. Epub 2008 Jul 23.

17.

Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.

Robinson BW, Behling KC, Gupta M, Zhang AY, Moore JS, Bantly AD, Willman CL, Carroll AJ, Adamson PC, Barrett JS, Felix CA.

Br J Haematol. 2008 Jun;141(6):827-39. doi: 10.1111/j.1365-2141.2008.07100.x. Epub 2008 Apr 18.

PMID:
18422996
18.

Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.

Robinson BW, Cheung NK, Kolaris CP, Jhanwar SC, Choi JK, Osheroff N, Felix CA.

Blood. 2008 Apr 1;111(7):3802-12. doi: 10.1182/blood-2007-07-096065. Epub 2008 Jan 14.

19.

Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation.

Nigro LL, Sainati L, Leszl A, Mirabile E, Spinelli M, Consarino C, Di Cataldo A, Magro S, Felix CA, Basso G.

Leukemia. 2007 Feb;21(2):360-2. Epub 2007 Jan 4. No abstract available.

PMID:
17205059
20.

Characterization of an etoposide-glutathione conjugate derived from metabolic activation by human cytochrome p450.

Zheng N, Pang S, Oe T, Felix CA, Wehrli S, Blair IA.

Curr Drug Metab. 2006 Dec;7(8):897-911.

PMID:
17168690
21.

Third-generation vs a second-generation LED curing light: effect on Knoop microhardness.

Price RB, Felix CA, Andreou P.

Compend Contin Educ Dent. 2006 Sep;27(9):490-6; quiz 497, 518.

PMID:
17052038
22.

Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.

Yocum AK, Busch CM, Felix CA, Blair IA.

J Proteome Res. 2006 Oct;5(10):2743-53.

PMID:
17022645
23.

Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group study.

Peters AM, Blair CK, Verneris MR, Neglia JP, Robison LL, Spector LG, Reaman GH, Felix CA, Ross JA; Children's Oncology Group.

Br J Cancer. 2006 Nov 6;95(9):1274-6. Epub 2006 Sep 26.

24.

Topoisomerase II and the etiology of chromosomal translocations.

Felix CA, Kolaris CP, Osheroff N.

DNA Repair (Amst). 2006 Sep 8;5(9-10):1093-108. Epub 2006 Jul 20. Review.

PMID:
16857431
26.
27.
28.

Evaluation of a dual peak third generation LED curing light.

Price RB, Felix CA, Andreou P.

Compend Contin Educ Dent. 2005 May;26(5):331-2, 334, 336-8 passim; quiz 348.

PMID:
15892221
29.

DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Ad├Ęs L, Blair IA, Osheroff N, Peniket AJ, Lafage-Pochitaloff M, Cross NC, Chomienne C, Solomon E, Fenaux P, Grimwade D.

N Engl J Med. 2005 Apr 14;352(15):1529-38.

30.

Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group.

Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD, Blair CK, Reaman GH, Ross JA.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):651-5.

31.

Knoop hardness of ten resin composites irradiated with high-power LED and quartz-tungsten-halogen lights.

Price RB, Felix CA, Andreou P.

Biomaterials. 2005 May;26(15):2631-41.

PMID:
15585266
32.

The molecular basis of leukemia.

Gilliland DG, Jordan CT, Felix CA.

Hematology Am Soc Hematol Educ Program. 2004:80-97. Review.

PMID:
15561678
33.
34.

Kinetics and regulation of cytochrome P450-mediated etoposide metabolism.

Zhuo X, Zheng N, Felix CA, Blair IA.

Drug Metab Dispos. 2004 Sep;32(9):993-1000.

PMID:
15319341
35.

1,4-Benzoquinone is a topoisomerase II poison.

Lindsey RH Jr, Bromberg KD, Felix CA, Osheroff N.

Biochemistry. 2004 Jun 15;43(23):7563-74.

PMID:
15182198
36.

Plasma etoposide catechol increases in pediatric patients undergoing multiple-day chemotherapy with etoposide.

Zheng N, Felix CA, Pang S, Boston R, Moate P, Scavuzzo J, Blair IA.

Clin Cancer Res. 2004 May 1;10(9):2977-85.

37.

Effects of resin composite composition and irradiation distance on the performance of curing lights.

Price RB, Felix CA, Andreou P.

Biomaterials. 2004 Aug;25(18):4465-77.

PMID:
15046937
38.

The effect of distance from light source on light intensity from curing lights.

Felix CA, Price RB.

J Adhes Dent. 2003 Winter;5(4):283-91.

PMID:
15008335
39.

Effect of disposable infection control barriers on light output from dental curing lights.

Scott BA, Felix CA, Price RB.

J Can Dent Assoc. 2004 Feb;70(2):105-10.

40.

Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.

Whitmarsh RJ, Saginario C, Zhuo Y, Hilgenfeld E, Rappaport EF, Megonigal MD, Carroll M, Liu M, Osheroff N, Cheung NK, Slater DJ, Ried T, Knutsen T, Blair IA, Felix CA.

Oncogene. 2003 Nov 20;22(52):8448-59.

PMID:
14627986
41.

Comparison of quartz-tungsten-halogen, light-emitting diode, and plasma arc curing lights.

Price RB, Ehrnford L, Andreou P, Felix CA.

J Adhes Dent. 2003 Fall;5(3):193-207.

PMID:
14621241
42.

Evaluation of a second-generation LED curing light.

Price RB, Felix CA, Andreou P.

J Can Dent Assoc. 2003 Nov;69(10):666.

43.

Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.

Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, Lange BJ, Felix CA.

Blood. 2002 Dec 15;100(13):4590-3. Epub 2002 Aug 1.

44.

The length of the retention interval, forgetting, and subjective similarity.

King DL, Jones FL, Pearlman RC, Tishman A, Felix CA.

J Exp Psychol Learn Mem Cogn. 2002 Jul;28(4):660-71.

PMID:
12109760
46.

p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer.

Leonard DG, Travis LB, Addya K, Dores GM, Holowaty EJ, Bergfeldt K, Malkin D, Kohler BA, Lynch CF, Wiklund T, Stovall M, Hall P, Pukkala E, Slater DJ, Felix CA.

Clin Cancer Res. 2002 May;8(5):973-85. Erratum in: Clin Cancer Res. 2002 Aug;8(8):2752-3.

47.

Isolated extramedullary relapse in acute myeloid leukemia: A retrospective analysis.

Ginsberg JP, Orudjev E, Bunin N, Felix CA, Lange BJ.

Med Pediatr Oncol. 2002 Jun;38(6):387-90.

PMID:
11984798
48.

Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.

Raffini LJ, Slater DJ, Rappaport EF, Lo Nigro L, Cheung NK, Biegel JA, Nowell PC, Lange BJ, Felix CA.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4568-73.

49.

Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000.

Felix CA, Lange BJ, Chessells JM.

Hematology Am Soc Hematol Educ Program. 2000:285-302.

PMID:
11701547
50.

Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.

Lovett BD, Lo Nigro L, Rappaport EF, Blair IA, Osheroff N, Zheng N, Megonigal MD, Williams WR, Nowell PC, Felix CA.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9802-7. Epub 2001 Aug 7.

Supplemental Content

Loading ...
Support Center